New York Assemblymember Amy Paulin (D) introduced a bill today that would provide legal access to psilocybin mushrooms
Psilocybin mushroom.
The legislation, Assembly Bill 10375, proposes a comprehensive framework for the “regulated adult use, support services, and cultivation of psilocybin-containing fungi.”
Psilocybin, the psychoactive compound found in “magic mushrooms,” has shown promise in clinical trials for treating a wide range of conditions, including depression, anxiety, and PTSD. This bill would establish a system for licensing and regulating psilocybin therapy, allowing qualified adults to possess and use the substance while establishing service centers where it can be used under the supervision of a licensed healthcare professional.
The bill defines a “licensed healthcare provider” broadly, encompassing professionals from various disciplines including medicine, social work, and mental health counseling. This could allow for a wider range of practitioners to participate in psilocybin-assisted therapy programs, once established.
The legislation also outlines a long list of qualifying health conditions for psilocybin treatment. This list is extensive, encompassing everything from anxiety and depression to chronic pain and end-of-life distress. Notably, the bill states that use of psilocybin is “not limited to” the conditions listed.
Assembly Bill 10375 has been assigned to the Assembly Health Committee for review. You can view the full text of the measure by clicking here.
